A twenty-six-week trial of Thymosin a1 plus famciclovir in the treatment of Chinese immune tolerant adult patients with chronic hepatitis B
A twenty-six-week trial of Thymosin a1 plus famciclovir in the treatment of Chinese immune tolerant adult patients with chronic hepatitis B is a paper indexed in ScholarIQ from OpenAlex.
How many citations does A twenty-six-week trial of Thymosin a1 plus famciclovir in the treatment of Chinese immune tolerant adult patients with chronic hepatitis B have?
A twenty-six-week trial of Thymosin a1 plus famciclovir in the treatment of Chinese immune tolerant adult patients with chronic hepatitis B has 1 citations in the OpenAlex counts ScholarIQ stores.
When was A twenty-six-week trial of Thymosin a1 plus famciclovir in the treatment of Chinese immune tolerant adult patients with chronic hepatitis B published?
A twenty-six-week trial of Thymosin a1 plus famciclovir in the treatment of Chinese immune tolerant adult patients with chronic hepatitis B has 1998 year in the ScholarIQ index.
What is the open-access status of A twenty-six-week trial of Thymosin a1 plus famciclovir in the treatment of Chinese immune tolerant adult patients with chronic hepatitis B?
A twenty-six-week trial of Thymosin a1 plus famciclovir in the treatment of Chinese immune tolerant adult patients with chronic hepatitis B has closed oa status in the ScholarIQ index.
What is the OpenAlex record for A twenty-six-week trial of Thymosin a1 plus famciclovir in the treatment of Chinese immune tolerant adult patients with chronic hepatitis B?
The OpenAlex for A twenty-six-week trial of Thymosin a1 plus famciclovir in the treatment of Chinese immune tolerant adult patients with chronic hepatitis B is on the source record.